Aβ peptides, which deposit in the brains of patients with Alzheimer’s disease (AD), are produced by the sequential cleavage of amyloid precursor protein (APP) by β-secretase 1 (BACE1) and γ-secretase. Here, BACE1 is linked to Alzheimer disease.